Scott Stratton is an industry leader in the design and development of products, technologies, business processes, and analytics. His focus is on collecting, integrating, organizing, mining, and modeling data to develop and optimize product development, sales, and profitability.
Scott has served as co-founder of CV-Sight, Vice President with Medco Health Solutions, Director at both Pfizer and Oxford Health Plans, and Assistant Vice President with GHI. Scott’s most significant design and development work includes Bayesian readmission analyses for one of the nation’s largest participants in CMS Innovation Center’s Bundled Payments for Care Initiative (BPCI); SAS70-compliant analytics to improve quality and costs of cardiac revascularizations; data models and processes supporting integrated pharmacy, hospital, medical, and ancillary claim data for >10 million lives, including episodes of care (ETGs) and ETG-based cost forecasting (ERGs); RightTrack™ Pfizer’s clinical trial management system still used after 13 years by the U.S. and 85 other countries for Phase II-IV trials; and co-founding Oxford’s global fees-oriented specialty management subsidiary.
Scott earned a Master’s Degree in Public Health from Yale’s School of Epidemiology and Public Health and a Bachelor of Arts in Philosophy from Carleton College. Additionally, Scott has been honored to serve on various state and national commissions, and was a founder of Yale’s John D. Thompson Fellowship Committee. CIO, American Demographics, and other periodicals have profiled him and he has published in the New England Journal of Medicine and most recently in the Journal of Clinical Oncology.